March 27, 2017
Strongbridge Biopharma plc Provides Corporate Update and Reports Full-Year 2016 Financial Results
Media
March 24, 2017
Nordic Nanovector publishes Annual Report 2016
March 23, 2017
HealthCap’s 39th IPO as HealthCap V company MIPS AB completes IPO on Nasdaq OMX Stockholm
March 23, 2017
Targovax ASA moves share listing to Oslo Børs
March 22, 2017
BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital
March 22, 2017
Nexstim Plc Signs an Independent Selling Representative Agreement in the U.S. with JTec Surgical, Inc.
March 22, 2017
Aprea Therapeutics Announces Research Collaboration with Memorial Sloan Kettering Cancer Center
March 17, 2017
Targovax ASA applies for transfer to Oslo Stock Exchange main list
March 17, 2017
Cerenis Therapeutics announces that CARAT Phase 2 Study data on CER-001 have been presented at ACC annual meeting 2017
March 17, 2017
Nordic Nanovector announces first patient dosed in Phase 1 study of Betalutin® in diffuse large B-cell lymphoma (DLBCL), an aggressive form of NHL
